JPH08510468A - アリール化剤 - Google Patents
アリール化剤Info
- Publication number
- JPH08510468A JPH08510468A JP7500384A JP50038495A JPH08510468A JP H08510468 A JPH08510468 A JP H08510468A JP 7500384 A JP7500384 A JP 7500384A JP 50038495 A JP50038495 A JP 50038495A JP H08510468 A JPH08510468 A JP H08510468A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- nitro
- halogen
- chloro
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/06—Phenols the aromatic ring being substituted by nitro groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/20—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings
- C07C205/21—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C205/24—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring having three, and only three, nitro groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/58—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/39—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing halogen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/40—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitro or nitroso groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/46—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
- C07C63/70—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939310520A GB9310520D0 (en) | 1993-05-21 | 1993-05-21 | Arylating agents |
GB9310520.3 | 1993-05-21 | ||
GB9405292.5 | 1994-03-17 | ||
GB9405292A GB9405292D0 (en) | 1993-05-21 | 1994-03-17 | Arylating agents |
PCT/GB1994/001126 WO1994027584A2 (en) | 1993-05-21 | 1994-05-23 | Arylating medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08510468A true JPH08510468A (ja) | 1996-11-05 |
Family
ID=26302926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7500384A Pending JPH08510468A (ja) | 1993-05-21 | 1994-05-23 | アリール化剤 |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0700287A1 (sk) |
JP (1) | JPH08510468A (sk) |
CN (1) | CN1124012A (sk) |
AP (1) | AP9400647A0 (sk) |
AU (1) | AU6729794A (sk) |
BG (1) | BG100242A (sk) |
BR (1) | BR9406548A (sk) |
CA (1) | CA2163459A1 (sk) |
CZ (1) | CZ307395A3 (sk) |
DZ (1) | DZ1781A1 (sk) |
FI (1) | FI955605A (sk) |
HU (1) | HUT77764A (sk) |
IL (1) | IL109712A0 (sk) |
MA (1) | MA23202A1 (sk) |
NO (1) | NO954702L (sk) |
OA (1) | OA10196A (sk) |
SK (1) | SK145795A3 (sk) |
WO (1) | WO1994027584A2 (sk) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1900195A (en) * | 1994-03-17 | 1995-10-03 | Radopath Limited | Anti-viral and anti-cancer agents |
GB2303790A (en) * | 1994-03-17 | 1997-03-05 | Radopath Ltd | Benzoic acid containing chloro and or nitro groups for cancer or viral therapy |
AU5115396A (en) * | 1995-03-17 | 1996-10-08 | Radopath Limited | Anti-viral and anti-cancer agents |
EP0817623B1 (de) * | 1995-03-30 | 2003-11-12 | Werner Prof. Dr. Kreutz | Arzneistoffe zur selektiven bekämpfung von tumorgewebe |
US5756548A (en) * | 1995-04-03 | 1998-05-26 | Centaur Pharmaceuticals, Inc. | Acetamidobenzamide compounds for neurodegenerative disorders |
GB9615619D0 (en) * | 1996-03-18 | 1996-09-04 | Radopath Ltd | Costimulation of TcR/CD3-induced T-Lymphocytes |
US5955506A (en) * | 1996-04-03 | 1999-09-21 | Centaur Pharmaceuticals, Inc. | Benzamides for neurodegenerative disorder treatment |
WO2007011962A2 (en) | 2005-07-18 | 2007-01-25 | Bipar Sciences, Inc. | Treatment of cancer |
US8143447B2 (en) | 2006-09-05 | 2012-03-27 | Bipar Sciences, Inc. | Treatment of cancer |
EP2217227B1 (en) | 2007-11-12 | 2013-08-21 | BiPar Sciences, Inc. | Treatment of breast cancer with 4-iodo-3-nitrobenzamide in combination with anti-tumor agents |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05169549A (ja) * | 1990-03-01 | 1993-07-09 | Teijin Seiki Co Ltd | 被覆ステーションを持つ立体的イメージング装置および方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1283331A (en) * | 1970-01-03 | 1972-07-26 | Smith Kline French Lab | Pharmaceutical compositions |
US3978119A (en) * | 1975-07-11 | 1976-08-31 | Gulf Research & Development Company | Process for converting stilbene or bibenzyl to nitrobenzoic acids |
US4283421A (en) * | 1979-12-19 | 1981-08-11 | Ray Frank F | Anti-viral treatment |
US4277492A (en) * | 1980-05-21 | 1981-07-07 | The Dow Chemical Company | Novel 4-bis((Phenylmethyl)amino)-benzenesulfonic acids possessing antiviral activity |
US4762705A (en) * | 1981-11-10 | 1988-08-09 | Adolf W. Schwimmer | Cancer therapy with interferon |
CA1262864A (en) * | 1982-09-17 | 1989-11-14 | Clarence D. Cone | Method for producing oncolysis |
US4935450A (en) * | 1982-09-17 | 1990-06-19 | Therapeutical Systems Corporation | Cancer therapy system for effecting oncolysis of malignant neoplasms |
JPS60224619A (ja) * | 1984-04-24 | 1985-11-09 | Adeka Argus Chem Co Ltd | 放射線増感剤 |
RO92333B1 (ro) * | 1985-06-18 | 1987-09-01 | Institutul De Cercetari Chimico-Farmaceutice | Produs radiosensibilizator al celulelor tumorale |
JPS6468315A (en) * | 1987-09-09 | 1989-03-14 | Yasuo Kawasaki | Antipyrotic of picric acid (2,4,6-trinitrophenol) |
WO1991011117A2 (en) * | 1990-02-05 | 1991-08-08 | Board Of Regents, The University Of Texas System | Dietary supplements comprising vitamins and minerals |
GB9103075D0 (en) * | 1991-02-13 | 1991-03-27 | Washington Odur Ayuko | Trinitrobenzene derivatives and their therapeutic use |
JPH06501449A (ja) * | 1990-04-03 | 1994-02-17 | ラドパス リミテッド | 癌またはウイル性疾患の治療におけるトリニトロベンゼン類またはカルミン酸の使用 |
US5422277A (en) * | 1992-03-27 | 1995-06-06 | Ortho Diagnostic Systems Inc. | Cell fixative composition and method of staining cells without destroying the cell surface |
-
1994
- 1994-05-18 DZ DZ940047A patent/DZ1781A1/fr active
- 1994-05-20 MA MA23512A patent/MA23202A1/fr unknown
- 1994-05-20 AP APAP/P/1994/000647A patent/AP9400647A0/en unknown
- 1994-05-22 IL IL10971294A patent/IL109712A0/xx unknown
- 1994-05-23 CZ CZ953073A patent/CZ307395A3/cs unknown
- 1994-05-23 HU HU9503327A patent/HUT77764A/hu unknown
- 1994-05-23 EP EP94915671A patent/EP0700287A1/en not_active Ceased
- 1994-05-23 AU AU67297/94A patent/AU6729794A/en not_active Abandoned
- 1994-05-23 JP JP7500384A patent/JPH08510468A/ja active Pending
- 1994-05-23 CA CA002163459A patent/CA2163459A1/en not_active Abandoned
- 1994-05-23 SK SK1457-95A patent/SK145795A3/sk unknown
- 1994-05-23 BR BR9406548A patent/BR9406548A/pt not_active Application Discontinuation
- 1994-05-23 WO PCT/GB1994/001126 patent/WO1994027584A2/en not_active Application Discontinuation
- 1994-05-23 CN CN94192181A patent/CN1124012A/zh active Pending
-
1995
- 1995-11-21 OA OA60743A patent/OA10196A/en unknown
- 1995-11-21 FI FI955605A patent/FI955605A/fi not_active Application Discontinuation
- 1995-11-21 NO NO954702A patent/NO954702L/no unknown
- 1995-12-21 BG BG100242A patent/BG100242A/bg unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05169549A (ja) * | 1990-03-01 | 1993-07-09 | Teijin Seiki Co Ltd | 被覆ステーションを持つ立体的イメージング装置および方法 |
Also Published As
Publication number | Publication date |
---|---|
BR9406548A (pt) | 1996-01-02 |
OA10196A (en) | 1996-12-18 |
AU6729794A (en) | 1994-12-20 |
FI955605A (fi) | 1996-01-22 |
SK145795A3 (en) | 1996-10-02 |
IL109712A0 (en) | 1994-08-26 |
WO1994027584A3 (en) | 1995-05-26 |
NO954702D0 (no) | 1995-11-21 |
EP0700287A1 (en) | 1996-03-13 |
BG100242A (bg) | 1996-07-31 |
WO1994027584A2 (en) | 1994-12-08 |
AP9400647A0 (en) | 1995-11-20 |
HU9503327D0 (en) | 1996-01-29 |
CZ307395A3 (en) | 1996-06-12 |
DZ1781A1 (fr) | 2002-02-17 |
NO954702L (no) | 1996-01-22 |
CA2163459A1 (en) | 1994-12-08 |
HUT77764A (hu) | 1998-08-28 |
CN1124012A (zh) | 1996-06-05 |
MA23202A1 (fr) | 1994-12-31 |
FI955605A0 (fi) | 1995-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9730902B2 (en) | Polyamine transport inhibitors as novel therapeutics | |
Schwab et al. | Amantadine in Parkinson's disease: review of more than two years' experience | |
Vane et al. | Mechanism of action of nonsteroidal anti-inflammatory drugs | |
NL9002720A (nl) | Blokkeermiddelen van edrf-effect of -vorming ter behandeling van shock. | |
JPH08510468A (ja) | アリール化剤 | |
Santana et al. | The nitric oxide donor cis-[Ru (bpy) 2 (SO3) NO](PF6) increases gastric mucosa protection in mice–Involvement of the soluble guanylate cyclase/KATP pathway | |
US20050192266A1 (en) | Vanadium (IV) metallocene complexes having spermicidal activity | |
PT1429807E (pt) | Combinação de um nsaid e de um inibidor de pde-4 | |
CA2273960C (en) | Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides | |
GB2284153A (en) | Therapeutic arylating agents | |
EP0987023A1 (en) | Transition metal complexes of non steroidal anti-inflammatory drugs | |
EP1016405A2 (en) | Arylating medicaments | |
JPH0314812B2 (sk) | ||
AP575A (en) | Anti viral and anti cancer agents. | |
Marini et al. | Gastric tolerability of nimesulide: a double-blind comparison of 2 oral dosage regimens and placebo | |
AR042153A1 (es) | Uso de los compuestos 2,5- dihidroxibencenosulfonicos para la fabricacion de un medicamento | |
JP2002308764A (ja) | 眼科用医薬組成物 | |
ES2619612T3 (es) | Formulaciones y métodos de tratamiento de afecciones de la piel | |
EP1631253A1 (en) | Sublingual administration of non-steroidal anti-inflammatory pharmacological substances | |
GB2303790A (en) | Benzoic acid containing chloro and or nitro groups for cancer or viral therapy | |
CA1307740C (en) | Pharmaceutical preparation and method for inhibiting replication of htlv-iii (aids) virus | |
JP2022546134A (ja) | 自閉症スペクトル障害の治療における使用のためのバフィデムスタット | |
JPH04169534A (ja) | 前立腺肥大症治療剤 | |
Smith et al. | Sulfones in Experimental Tuberculosis: Chemical Constitution and Chemotherapeutic Action | |
EP0009046A1 (en) | Composition containing salicylsalicyclic acid and acetaminophen |